María Casal-Domínguez

2.3k total citations
35 papers, 1.3k citations indexed

About

María Casal-Domínguez is a scholar working on Epidemiology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, María Casal-Domínguez has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 19 papers in Rheumatology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in María Casal-Domínguez's work include Inflammatory Myopathies and Dermatomyositis (32 papers), Eosinophilic Disorders and Syndromes (17 papers) and Systemic Sclerosis and Related Diseases (9 papers). María Casal-Domínguez is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (32 papers), Eosinophilic Disorders and Syndromes (17 papers) and Systemic Sclerosis and Related Diseases (9 papers). María Casal-Domínguez collaborates with scholars based in United States, Spain and Palestinian Territory. María Casal-Domínguez's co-authors include Iago Pinal‐Fernandez, Andrew L. Mammen, Lisa Christopher‐Stine, Julie J. Paik, Jemima Albayda, Sonye K. Danoff, Cheilonda Johnson, Thomas E. Lloyd, J.A. Huapaya and Andrea M. Corse and has published in prestigious journals such as Neurology, CHEST Journal and Annals of the Rheumatic Diseases.

In The Last Decade

María Casal-Domínguez

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
María Casal-Domínguez United States 18 1.1k 426 305 232 220 35 1.3k
Benjamin A. Fisher United Kingdom 22 184 0.2× 474 1.1× 231 0.8× 425 1.8× 40 0.2× 66 1.6k
Yeong‐Jian Jan Wu Taiwan 16 284 0.3× 537 1.3× 173 0.6× 279 1.2× 33 0.1× 38 970
Jihao Zhou United States 17 411 0.4× 811 1.9× 391 1.3× 167 0.7× 163 0.7× 61 1.7k
Mária Filková Czechia 20 377 0.4× 518 1.2× 422 1.4× 330 1.4× 21 0.1× 49 1.5k
Takahiro Ito Japan 19 206 0.2× 99 0.2× 366 1.2× 124 0.5× 77 0.3× 94 1.4k
Stephen Hall United States 13 329 0.3× 286 0.7× 96 0.3× 43 0.2× 64 0.3× 16 748
Iván Ferraz‐Amaro Spain 20 216 0.2× 916 2.2× 228 0.7× 396 1.7× 18 0.1× 144 1.5k
Fernanda Genre Spain 21 156 0.1× 605 1.4× 381 1.2× 447 1.9× 19 0.1× 85 1.2k
Collette McCourt United Kingdom 9 83 0.1× 547 1.3× 158 0.5× 369 1.6× 37 0.2× 27 1.0k
Jay Tuttle United States 16 271 0.3× 54 0.1× 204 0.7× 336 1.4× 27 0.1× 40 1.1k

Countries citing papers authored by María Casal-Domínguez

Since Specialization
Citations

This map shows the geographic impact of María Casal-Domínguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Casal-Domínguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Casal-Domínguez more than expected).

Fields of papers citing papers by María Casal-Domínguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Casal-Domínguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Casal-Domínguez. The network helps show where María Casal-Domínguez may publish in the future.

Co-authorship network of co-authors of María Casal-Domínguez

This figure shows the co-authorship network connecting the top 25 collaborators of María Casal-Domínguez. A scholar is included among the top collaborators of María Casal-Domínguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Casal-Domínguez. María Casal-Domínguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinal‐Fernandez, Iago, María Casal-Domínguez, Katherine Pak, et al.. (2025). Distinct cytokine and cytokine receptor expression patterns characterize different forms of myositis. Lara D. Veeken. 64(11). 5751–5760. 1 indexed citations
2.
Pak, Katherine, Iago Pinal‐Fernandez, María Casal-Domínguez, et al.. (2025). Myositis-specific autoantibodies recognising Mi2 also target the AIRE protein at a shared PHD zinc finger. Annals of the Rheumatic Diseases. 85(2). 351–359. 1 indexed citations
3.
Pinal‐Fernandez, Iago, María Casal-Domínguez, Katherine Pak, et al.. (2025). Anti-Mi2 autoantibodies target PHD fingers of SP140L and TIF1γ, while anti-TIF1γ autoantibodies primarily bind TIF1γ outside the PHD region. Lara D. Veeken. 64(12). 6371–6377. 2 indexed citations
4.
Kleefeld, Felix, Rita Horváth, Iago Pinal‐Fernandez, et al.. (2024). Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2. Acta Neuropathologica. 147(1). 19–19. 6 indexed citations
5.
Torres‐Ruiz, Jiram, Iago Pinal‐Fernandez, Albert Selva-O’Callaghan, et al.. (2024). Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies. Clinical and Experimental Rheumatology. 42(2). 367–376. 4 indexed citations
6.
Kobrin, Dale, et al.. (2023). A comprehensive review of dermatomyositis treatments - from rediscovered classics to promising horizons. Expert Review of Clinical Immunology. 20(2). 197–209. 5 indexed citations
7.
Pinal‐Fernandez, Iago, María Casal-Domínguez, Jemima Albayda, et al.. (2023). Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis. Neurology. 100(13). 14 indexed citations
8.
Pinal‐Fernandez, Iago, María Casal-Domínguez, Katherine Pak, et al.. (2023). Identification of Unique microRNA Profiles in Different Types of Idiopathic Inflammatory Myopathy. Cells. 12(17). 2198–2198. 9 indexed citations
9.
Casal-Domínguez, María, Iago Pinal‐Fernandez, & Andrew L. Mammen. (2022). Utility of Myositis-Specific Autoantibodies for Treatment Selection in Myositis. PubMed. 8(4). 105–116. 1 indexed citations
10.
Pinal‐Fernandez, Iago, Katherine Pak, Albert Gil‐Vila, et al.. (2021). Anti‐Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis. Arthritis & Rheumatology. 74(2). 358–364. 6 indexed citations
11.
Casal-Domínguez, María, Iago Pinal‐Fernandez, Katherine Pak, et al.. (2021). Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis‐Specific Autoantibodies. Arthritis & Rheumatology. 74(3). 508–517. 29 indexed citations
12.
Casal-Domínguez, María, Iago Pinal‐Fernandez, Katherine Pak, et al.. (2021). The indirect immunofluorescence assay autoantibody profiles of myositis patients without known myositis-specific autoantibodies. Clinical and Experimental Rheumatology. 39(3). 519–524. 2 indexed citations
13.
Pinal‐Fernandez, Iago, María Casal-Domínguez, Jemima Albayda, et al.. (2021). Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis. Clinical Rheumatology. 40(10). 4095–4100. 21 indexed citations
14.
Casal-Domínguez, María, Iago Pinal‐Fernandez, & Andrew L. Mammen. (2021). Inhibiting Interferon Pathways in Dermatomyositis: Rationale and Preliminary Evidence. PubMed. 7(3). 258–271. 6 indexed citations
15.
Casal-Domínguez, María, Iago Pinal‐Fernandez, Assia Derfoul, et al.. (2021). The phenotype of myositis patients with anti-Ku autoantibodies. Seminars in Arthritis and Rheumatism. 51(4). 728–734. 19 indexed citations
16.
Pinal‐Fernandez, Iago, Christopher A. Mecoli, María Casal-Domínguez, et al.. (2019). More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies. Neurology. 93(19). e1768–e1777. 34 indexed citations
17.
Huapaya, J.A., Robert W. Hallowell, Leann Silhan, et al.. (2019). Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease. Respiratory Medicine. 154. 6–11. 34 indexed citations
18.
Huapaya, J.A., Leann Silhan, Iago Pinal‐Fernandez, et al.. (2019). Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease. CHEST Journal. 156(5). 896–906. 73 indexed citations
19.
Pinal‐Fernandez, Iago, María Casal-Domínguez, Assia Derfoul, et al.. (2019). Identification of distinctive interferon gene signatures in different types of myositis. Neurology. 93(12). e1193–e1204. 140 indexed citations
20.
Pinal‐Fernandez, Iago, María Casal-Domínguez, & Andrew L. Mammen. (2018). Immune-Mediated Necrotizing Myopathy. Current Rheumatology Reports. 20(4). 21–21. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin A. Fisher Breakdown of academic impact, for papers by Yeong‐Jian Jan Wu Breakdown of academic impact, for papers by Jihao Zhou Breakdown of academic impact, for papers by Mária Filková Breakdown of academic impact, for papers by Takahiro Ito Breakdown of academic impact, for papers by Stephen Hall Breakdown of academic impact, for papers by Iván Ferraz‐Amaro Breakdown of academic impact, for papers by Fernanda Genre Breakdown of academic impact, for papers by Collette McCourt Breakdown of academic impact, for papers by Jay Tuttle
Rankless by CCL
2026